Global and United States Cell and Gene Therapy Manufacturing Services Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 Cell and Gene Therapy Manufacturing Services Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Cell and Gene Therapy Manufacturing Services Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Cell and Gene Therapy Manufacturing Services Market Size for the Year 2017-2028
  • 1.2.2 Global Cell and Gene Therapy Manufacturing Services Market Size for the Year 2017-2028
• 1.3 Cell and Gene Therapy Manufacturing Services Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.3.1 The Market Share of United States Cell and Gene Therapy Manufacturing Services in Global, 2017 VS 2022 VS 2028
  • 1.3.2 The Growth Rate of Cell and Gene Therapy Manufacturing Services Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.4 Cell and Gene Therapy Manufacturing Services Market Dynamics
  • 1.4.1 Cell and Gene Therapy Manufacturing Services Industry Trends
  • 1.4.2 Cell and Gene Therapy Manufacturing Services Market Drivers
  • 1.4.3 Cell and Gene Therapy Manufacturing Services Market Challenges
  • 1.4.4 Cell and Gene Therapy Manufacturing Services Market Restraints
• 1.5 Study Objectives
• 1.6 Years Considered

2 Cell and Gene Therapy Manufacturing Services by Type

• 2.1 Cell and Gene Therapy Manufacturing Services Market Segment by Type
  • 2.1.1 Allogeneic
  • 2.1.2 Autologous
  • 2.1.3 Viral Vector
• 2.2 Global Cell and Gene Therapy Manufacturing Services Market Size by Type (2017, 2022 & 2028)
• 2.3 Global Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2028)
• 2.4 United States Cell and Gene Therapy Manufacturing Services Market Size by Type (2017, 2022 & 2028)
• 2.5 United States Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2028)

3 Cell and Gene Therapy Manufacturing Services by Application

• 3.1 Cell and Gene Therapy Manufacturing Services Market Segment by Application
  • 3.1.1 Oncology Diseases
  • 3.1.2 Cardiovascular Diseases
  • 3.1.3 Orthopedic Diseases
  • 3.1.4 Ophthalmology Diseases
  • 3.1.5 Infectious Diseases
  • 3.1.6 Others
• 3.2 Global Cell and Gene Therapy Manufacturing Services Market Size by Application (2017, 2022 & 2028)
• 3.3 Global Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2028)
• 3.4 United States Cell and Gene Therapy Manufacturing Services Market Size by Application (2017, 2022 & 2028)
• 3.5 United States Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2028)

4 Global Cell and Gene Therapy Manufacturing Services Competitor Landscape by Company

• 4.1 Global Cell and Gene Therapy Manufacturing Services Market Size by Company
  • 4.1.1 Top Global Cell and Gene Therapy Manufacturing Services Companies Ranked by Revenue (2021)
  • 4.1.2 Global Cell and Gene Therapy Manufacturing Services Revenue by Player (2017-2022)
• 4.2 Global Cell and Gene Therapy Manufacturing Services Concentration Ratio (CR)
  • 4.2.1 Cell and Gene Therapy Manufacturing Services Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Companies of Cell and Gene Therapy Manufacturing Services in 2021
  • 4.2.3 Global Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Cell and Gene Therapy Manufacturing Services Headquarters, Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million) Type
  • 4.3.1 Global Cell and Gene Therapy Manufacturing Services Headquarters and Area Served
  • 4.3.2 Global Cell and Gene Therapy Manufacturing Services Companies Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022) & (US$ Million) Type
  • 4.3.3 Date of International Companies Enter into Cell and Gene Therapy Manufacturing Services Market
• 4.4 Companies Mergers & Acquisitions, Expansion Plans
• 4.5 United States Cell and Gene Therapy Manufacturing Services Market Size by Company
  • 4.5.1 Top Cell and Gene Therapy Manufacturing Services Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Cell and Gene Therapy Manufacturing Services Revenue by Players (2020, 2021 & 2022)

5 Global Cell and Gene Therapy Manufacturing Services Market Size by Region

• 5.1 Global Cell and Gene Therapy Manufacturing Services Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Cell and Gene Therapy Manufacturing Services Market Size by Region (2017-2028)
  • 5.2.1 Global Cell and Gene Therapy Manufacturing Services Market Size by Region: 2017-2022
  • 5.2.2 Global Cell and Gene Therapy Manufacturing Services Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Cell and Gene Therapy Manufacturing Services Market Size YoY Growth 2017-2028
  • 6.1.2 North America Cell and Gene Therapy Manufacturing Services Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Cell and Gene Therapy Manufacturing Services Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Cell and Gene Therapy Manufacturing Services Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Cell and Gene Therapy Manufacturing Services Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
  • 6.4.6 Colombia
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 Thermo Fisher Scientific
  • 7.1.1 Thermo Fisher Scientific Company Details
  • 7.1.2 Thermo Fisher Scientific Business Overview
  • 7.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Introduction
  • 7.1.4 Thermo Fisher Scientific Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.1.5 Thermo Fisher Scientific Recent Development
• 7.2 Merck KGaA
  • 7.2.1 Merck KGaA Company Details
  • 7.2.2 Merck KGaA Business Overview
  • 7.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Introduction
  • 7.2.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.2.5 Merck KGaA Recent Development
• 7.3 Charles River Laboratories
  • 7.3.1 Charles River Laboratories Company Details
  • 7.3.2 Charles River Laboratories Business Overview
  • 7.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Introduction
  • 7.3.4 Charles River Laboratories Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.3.5 Charles River Laboratories Recent Development
• 7.4 Lonza
  • 7.4.1 Lonza Company Details
  • 7.4.2 Lonza Business Overview
  • 7.4.3 Lonza Cell and Gene Therapy Manufacturing Services Introduction
  • 7.4.4 Lonza Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.4.5 Lonza Recent Development
• 7.5 Catalent
  • 7.5.1 Catalent Company Details
  • 7.5.2 Catalent Business Overview
  • 7.5.3 Catalent Cell and Gene Therapy Manufacturing Services Introduction
  • 7.5.4 Catalent Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.5.5 Catalent Recent Development
• 7.6 WuXi AppTec
  • 7.6.1 WuXi AppTec Company Details
  • 7.6.2 WuXi AppTec Business Overview
  • 7.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Introduction
  • 7.6.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.6.5 WuXi AppTec Recent Development
• 7.7 Takara Bio Inc
  • 7.7.1 Takara Bio Inc Company Details
  • 7.7.2 Takara Bio Inc Business Overview
  • 7.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Introduction
  • 7.7.4 Takara Bio Inc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.7.5 Takara Bio Inc Recent Development
• 7.8 Nikon Corporation
  • 7.8.1 Nikon Corporation Company Details
  • 7.8.2 Nikon Corporation Business Overview
  • 7.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Introduction
  • 7.8.4 Nikon Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.8.5 Nikon Corporation Recent Development
• 7.9 FUJIFILM Holdings Corporation
  • 7.9.1 FUJIFILM Holdings Corporation Company Details
  • 7.9.2 FUJIFILM Holdings Corporation Business Overview
  • 7.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Introduction
  • 7.9.4 FUJIFILM Holdings Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.9.5 FUJIFILM Holdings Corporation Recent Development
• 7.10 F. Hoffmann-La Roche
  • 7.10.1 F. Hoffmann-La Roche Company Details
  • 7.10.2 F. Hoffmann-La Roche Business Overview
  • 7.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Introduction
  • 7.10.4 F. Hoffmann-La Roche Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.10.5 F. Hoffmann-La Roche Recent Development
• 7.11 Oxford Biomedica Plc
  • 7.11.1 Oxford Biomedica Plc Company Details
  • 7.11.2 Oxford Biomedica Plc Business Overview
  • 7.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Introduction
  • 7.11.4 Oxford Biomedica Plc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.11.5 Oxford Biomedica Plc Recent Development
• 7.12 Cell and Gene Therapy Catapult
  • 7.12.1 Cell and Gene Therapy Catapult Company Details
  • 7.12.2 Cell and Gene Therapy Catapult Business Overview
  • 7.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Introduction
  • 7.12.4 Cell and Gene Therapy Catapult Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.12.5 Cell and Gene Therapy Catapult Recent Development
• 7.13 The Discovery Labs LLC
  • 7.13.1 The Discovery Labs LLC Company Details
  • 7.13.2 The Discovery Labs LLC Business Overview
  • 7.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Introduction
  • 7.13.4 The Discovery Labs LLC Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.13.5 The Discovery Labs LLC Recent Development
• 7.14 RoslinCT
  • 7.14.1 RoslinCT Company Details
  • 7.14.2 RoslinCT Business Overview
  • 7.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Introduction
  • 7.14.4 RoslinCT Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.14.5 RoslinCT Recent Development
• 7.15 JRS PHARMA
  • 7.15.1 JRS PHARMA Company Details
  • 7.15.2 JRS PHARMA Business Overview
  • 7.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Introduction
  • 7.15.4 JRS PHARMA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.15.5 JRS PHARMA Recent Development
• 7.16 FinVector
  • 7.16.1 FinVector Company Details
  • 7.16.2 FinVector Business Overview
  • 7.16.3 FinVector Cell and Gene Therapy Manufacturing Services Introduction
  • 7.16.4 FinVector Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.16.5 FinVector Recent Development
• 7.17 ABL
  • 7.17.1 ABL Company Details
  • 7.17.2 ABL Business Overview
  • 7.17.3 ABL Cell and Gene Therapy Manufacturing Services Introduction
  • 7.17.4 ABL Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.17.5 ABL Recent Development
• 7.18 Resilience
  • 7.18.1 Resilience Company Details
  • 7.18.2 Resilience Business Overview
  • 7.18.3 Resilience Cell and Gene Therapy Manufacturing Services Introduction
  • 7.18.4 Resilience Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.18.5 Resilience Recent Development
• 7.19 BioCentriq
  • 7.19.1 BioCentriq Company Details
  • 7.19.2 BioCentriq Business Overview
  • 7.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Introduction
  • 7.19.4 BioCentriq Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.19.5 BioCentriq Recent Development
• 7.20 Porton Biopharma Limited
  • 7.20.1 Porton Biopharma Limited Company Details
  • 7.20.2 Porton Biopharma Limited Business Overview
  • 7.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Introduction
  • 7.20.4 Porton Biopharma Limited Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.20.5 Porton Biopharma Limited Recent Development
• 7.21 Andelyn Biosciences
  • 7.21.1 Andelyn Biosciences Company Details
  • 7.21.2 Andelyn Biosciences Business Overview
  • 7.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Introduction
  • 7.21.4 Andelyn Biosciences Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.21.5 Andelyn Biosciences Recent Development
• 7.22 Commercializing Living Therapies
  • 7.22.1 Commercializing Living Therapies Company Details
  • 7.22.2 Commercializing Living Therapies Business Overview
  • 7.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Introduction
  • 7.22.4 Commercializing Living Therapies Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.22.5 Commercializing Living Therapies Recent Development
• 7.23 Vibalogics
  • 7.23.1 Vibalogics Company Details
  • 7.23.2 Vibalogics Business Overview
  • 7.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Introduction
  • 7.23.4 Vibalogics Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.23.5 Vibalogics Recent Development
• 7.24 Anemocyte Srl
  • 7.24.1 Anemocyte Srl Company Details
  • 7.24.2 Anemocyte Srl Business Overview
  • 7.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Introduction
  • 7.24.4 Anemocyte Srl Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.24.5 Anemocyte Srl Recent Development
• 7.25 ElevateBio
  • 7.25.1 ElevateBio Company Details
  • 7.25.2 ElevateBio Business Overview
  • 7.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Introduction
  • 7.25.4 ElevateBio Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
  • 7.25.5 ElevateBio Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
  • 9.1.1 Methodology/Research Approach
  • 9.1.2 Data Source
• 9.2 Author Details